Skip to main content

Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.

Schubert P, Culibrk B, Karwal S, Serrano K, Levin E, Bu D, Bhakta V, Sheffield WP, Goodrich RP, Devine DV

Publication: Transfusion (2015) • Vol 55(4) • Page 815-23PMID: 25355434View on PubMed

Purpose

The purpose of this paper was to compare storage properties of red blood cells (RBCs), plasma and platelets (Plts) from untreated blood with those obtained from blood that was Mirasol-treated.

Conclusion

When whole blood was Mirasol (ultraviolet and riboflavin)-treated before separation of the Plts, RBC and plasma by the buffy-coat method, the resultant Plts were less affected by storage than Plts treated after separation. In contrast, RBCs from Mirasol-treated blood showed faster RBC deterioration with storage, and plasma from Mirasol-treated blood had reduced coagulation factors and prolonged clotting times compared to those from untreated blood.

Studies (3)

Purpose

The purpose of this study was to determine the effect of Mirasol treatment of whole blood versus Plts and storage duration on markers of Plt quality. The experiment was conducted 6 times. Each experiment involved pooling 8 whole blood units which were split and treated with Mirasol or not, and then held overnight before being processed by the buffy-coat method into plasma, RBCs and Plts. Plts from untreated blood were Mirasol-treated, and stored along with those from Mirasol-treated blood in illumination bags at 20-24°C with constant agitation for up to 7 days.

Summary of Findings

With increasing storage duration, glucose levels, extent of shape change (ESC), and response to Plt activation declined, and lactate levels, Plt activation, and the percentage of Plts expressing annexin V increased, but the changes tended to be smaller when whole blood rather than the Plts was treated with Mirasol. When blood rather than Plts was treated with Mirasol, lactate levels were higher on day 1 and 2 (p<0.05), ESC was higher on day 2 and 7 (p<0.05, both), the response to Plt activation was higher on days 2, 5 and 7 (p<0.05, all), pH and glucose levels were higher and the percentage of Annexin V positive Plts was lower on day 5 (p<0.05, all) and 7 (p<0.05, all), and there was lower Plt activation on day 7 (p<0.05). There was no effect of the timing of Mirasol treatment on Plt concentration, or mean Plt volume (MPV).

  • Biospecimens

    FluidBlood
  • Preservation Types

    None (Fresh)
  • Diagnoses

    Not specified
  • Platforms

    Cell count/volumeHematology/ auto analyzer
    Cell count/volumeFlow cytometry
    Electrolyte/MetalClinical chemistry/auto analyzer
    CarbohydrateClinical chemistry/auto analyzer
    GasClinical chemistry/auto analyzer
    Small moleculeClinical chemistry/auto analyzer
    MorphologyFlow cytometry
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsBlood processing method
    Mirasol treatment of platelets
    Mirasol treatment of whole blood
    StorageTime at room temperature
    1 day
    2 days
    5 days
    7 days